Pharmacovigilance


At Convex, we are committed to safeguarding patient safety and supporting our partners with end-to-end pharmacovigilance (PV) solutions. With over three decades of experience in clinical research and regulatory operations, we now extend our expertise to provide comprehensive drug safety services.

Our pharmacovigilance team specializes in monitoring, assessing, and reporting adverse events (AEs) and serious adverse events (SAEs) in accordance with global regulatory standards (FDA, EMA, ICH, GVP).

Core Pharmacovigilance Services


Regulatory Compliance
  • Eudravigilance registration/updates
  • XEVMPD registration of IMP
  • Study protocol documentation
  • IMP documentation (IB, IMPD)
  • Safety Management Plan
  • TMF safety part activities
first-in-human-2

Safety Monitoring & Reporting
  • SAE/overdose/pregnancy reporting
  • Safety Database management
  • CIOMS-I forms generation
  • Signal detection activities
  • SUSAR reporting in EU
  • Periodic reporting
Quality Management
  • Quality control of safety data
  • SAE reconciliations
  • MedDRA coding of AEs
  • DSUR preparation
  • Compliance tracking
  • Documentation management
Phase1 Clinical Trials

Let us help you navigate the complexities of global pharmacovigilance with confidence. Contact us at: info@convex.bg